1. Home
  2. AMPY vs ARMP Comparison

AMPY vs ARMP Comparison

Compare AMPY & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amplify Energy Corp.

AMPY

Amplify Energy Corp.

N/A

Current Price

$4.90

Market Cap

199.8M

Sector

Energy

ML Signal

N/A

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

N/A

Current Price

$5.84

Market Cap

199.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMPY
ARMP
Founded
2011
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
199.8M
199.7M
IPO Year
2011
1996

Fundamental Metrics

Financial Performance
Metric
AMPY
ARMP
Price
$4.90
$5.84
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$15.00
AVG Volume (30 Days)
917.4K
94.5K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
232.26
N/A
EPS
N/A
N/A
Revenue
$208,637,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$23.83
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.65
$2.79
52 Week High
$6.79
$14.98

Technical Indicators

Market Signals
Indicator
AMPY
ARMP
Relative Strength Index (RSI) 60.44 53.24
Support Level $4.49 $5.12
Resistance Level $5.07 $5.63
Average True Range (ATR) 0.16 0.48
MACD 0.01 0.08
Stochastic Oscillator 68.09 77.22

Price Performance

Historical Comparison
AMPY
ARMP

About AMPY Amplify Energy Corp.

Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The companies oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

Share on Social Networks: